BE2014C050I2 - Circovirus sequences associated with piglet weight loss disease (PWD) - Google Patents
Circovirus sequences associated with piglet weight loss disease (PWD)Info
- Publication number
- BE2014C050I2 BE2014C050I2 BE2014C050C BE2014C050C BE2014C050I2 BE 2014C050 I2 BE2014C050 I2 BE 2014C050I2 BE 2014C050 C BE2014C050 C BE 2014C050C BE 2014C050 C BE2014C050 C BE 2014C050C BE 2014C050 I2 BE2014C050 I2 BE 2014C050I2
- Authority
- BE
- Belgium
- Prior art keywords
- pwd
- circovirus
- polypeptides
- vectors
- weight loss
- Prior art date
Links
- 241001533384 Circovirus Species 0.000 title abstract 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 208000016261 weight loss Diseases 0.000 title 1
- 230000004580 weight loss Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 239000013598 vector Substances 0.000 abstract 3
- 208000036142 Viral infection Diseases 0.000 abstract 2
- 230000009385 viral infection Effects 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10051—Methods of production or purification of viral material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10061—Methods of inactivation or attenuation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9715396A FR2772047B1 (fr) | 1997-12-05 | 1997-12-05 | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
PCT/FR1998/002634 WO1999029871A2 (fr) | 1997-12-05 | 1998-12-04 | Sequences de circovirus associe a la maladie de l'amaigrissement du porcelet (map) |
Publications (1)
Publication Number | Publication Date |
---|---|
BE2014C050I2 true BE2014C050I2 (en) | 2018-07-04 |
Family
ID=9514225
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE2014C049C BE2014C049I2 (en) | 1997-12-05 | 2014-08-14 | Circovirus sequences associated with piglet weight loss disease (PWD) |
BE2014C050C BE2014C050I2 (en) | 1997-12-05 | 2014-08-14 | Circovirus sequences associated with piglet weight loss disease (PWD) |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE2014C049C BE2014C049I2 (en) | 1997-12-05 | 2014-08-14 | Circovirus sequences associated with piglet weight loss disease (PWD) |
Country Status (15)
Country | Link |
---|---|
US (43) | US6703023B1 (fr) |
EP (6) | EP1992696B1 (fr) |
AT (1) | ATE412664T1 (fr) |
AU (1) | AU1491699A (fr) |
BE (2) | BE2014C049I2 (fr) |
CY (6) | CY1115405T1 (fr) |
DE (1) | DE69840174D1 (fr) |
DK (5) | DK2000535T3 (fr) |
ES (5) | ES2548146T3 (fr) |
FR (3) | FR2772047B1 (fr) |
HK (5) | HK1125676A1 (fr) |
LU (2) | LU92524I2 (fr) |
NL (2) | NL300686I2 (fr) |
PT (5) | PT1036180E (fr) |
WO (1) | WO1999029871A2 (fr) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002302120B2 (en) * | 1997-10-03 | 2006-01-19 | Merial | Porcine circoviruses, vaccines and diagnostic reagents |
US7192594B2 (en) | 1997-10-03 | 2007-03-20 | Merial Limited | Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
US6517843B1 (en) * | 1999-08-31 | 2003-02-11 | Merial | Reduction of porcine circovirus-2 viral load with inactivated PCV-2 |
US7211379B2 (en) | 1997-10-03 | 2007-05-01 | Merial Sas | Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2 |
AU2003248395B2 (en) * | 1997-10-03 | 2006-03-16 | Merial | Porcine CircoViruses, vaccines and diagnostic reagents |
US6391314B1 (en) | 1997-10-03 | 2002-05-21 | Merial | Porcine circoviruses vaccines diagnostic reagents |
UA78180C2 (uk) * | 1997-10-03 | 2007-03-15 | Меріаль | Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти |
FR2772047B1 (fr) * | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
PT1037909E (pt) * | 1997-12-11 | 2007-09-07 | Merial Sas | Síndrome multi-sistémica do definhamento pós-desmame de porcos |
EP1816200B1 (fr) * | 1997-12-11 | 2016-03-09 | Merial | Virus de syndrome de dépérissement post-sevrage pour cochons |
US6287856B1 (en) * | 1998-03-13 | 2001-09-11 | University Of Georgia Research Foundation, Inc. | Vaccines against circovirus infections |
US6943152B1 (en) | 1999-06-10 | 2005-09-13 | Merial | DNA vaccine-PCV |
ES2170622B1 (es) * | 1999-12-03 | 2004-05-16 | Consejo Superior De Investigaciones Cientificas | Clones y vectores infectivos derivados de coronavirus y sus aplicaciones. |
WO2001061024A2 (fr) | 2000-02-16 | 2001-08-23 | Large Scale Biology Corporation | Vecteurs d'expression de replicon en cercle roulant |
JP4038127B2 (ja) | 2001-03-27 | 2008-01-23 | ユニバーシティ オブ サスカチュワン | サーコウイルスの培養方法 |
US7276353B2 (en) | 2001-12-12 | 2007-10-02 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
US7279166B2 (en) | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
DK2281829T3 (da) | 2004-12-30 | 2015-02-23 | Boehringer Ingelheim Vetmed | PCV2-immunogene sammensætninger til anvendelse i en fremgangsmåde til forebyggelse af PCV2-infektion |
US7700285B1 (en) | 2005-12-29 | 2010-04-20 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 immunogenic compositions and methods of producing such compositions |
AU2011253941B2 (en) * | 2004-12-30 | 2015-01-29 | Boehringer Ingelheim Animal Health USA Inc. | PCV2 immunogenic compositions and methods of producing such compositions |
UA95602C2 (ru) | 2004-12-30 | 2011-08-25 | Берингер Ингельхейм Ветмедика, Инк. | Иммуногенная композиция цвс2 и способы приготовления такой композиции |
US7833707B2 (en) | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
ITBO20050123A1 (it) | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
WO2006132598A1 (fr) * | 2005-06-07 | 2006-12-14 | Temasek Life Sciences Laboratory Limited | Vaccins contre le circovirus porcin de type 2 |
RU2389506C2 (ru) * | 2005-09-09 | 2010-05-20 | Интервет Интернэшнл Б.В. | Вакцина против рсv-2 |
DK2371382T3 (en) | 2005-12-29 | 2016-06-13 | Boehringer Ingelheim Vetmedica Inc | Use of a PCV2 immunogenic composition to reduce the clinical signs in swine |
RU2488407C2 (ru) | 2005-12-29 | 2013-07-27 | Берингер Ингельхайм Ветмедика, Инк. | Поливалентные иммуногенные композиции pcv2 и способы получения таких композиций |
WO2008064299A2 (fr) * | 2006-11-22 | 2008-05-29 | Boehringer Ingelheim Vetmedica, Inc. | Procédés de réduction des flambées des maladies associées au circovirus porcin |
US20100129397A1 (en) * | 2006-12-11 | 2010-05-27 | Boehringer Ingelheim Vetmedica, Inc. | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
BRPI0721083A2 (pt) | 2006-12-15 | 2014-02-25 | Boehringer Ingelheim Vetmed | Tratamento de porcos com antígeno de pcv2 |
EP1941903A1 (fr) | 2007-01-03 | 2008-07-09 | Boehringer Ingelheim Vetmedica Gmbh | Prophylaxie et traitement du PRDC |
EP1958644A1 (fr) | 2007-02-13 | 2008-08-20 | Boehringer Ingelheim Vetmedica Gmbh | Prévention et traitement du PCVD subclinique |
AU2007353480B2 (en) * | 2007-05-11 | 2013-09-19 | Temasek Life Sciences Laboratory Limited | Production of a homogeneous cell line highly permissive to porcine circovirus type 2 (PCV2) infection |
US7829274B2 (en) | 2007-09-04 | 2010-11-09 | Boehringer Ingelheim Vetmedica, Inc. | Reduction of concomitant infections in pigs by the use of PCV2 antigen |
BRPI0821286A8 (pt) * | 2007-12-21 | 2017-08-15 | Wyeth Llc | Métodos e composições para imunizar porcos contra circovirus suino |
AU2008347235A1 (en) * | 2007-12-31 | 2009-07-16 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 ORF2 virus like particle with foreign amino acid insertion |
WO2009126356A2 (fr) * | 2008-01-23 | 2009-10-15 | Boehringer Ingelheim Vetmedica, Inc. | Compositions immunogènes de mycoplasma hyopneumoniae pcv2, et procédés de production de telles compositions |
US20110033495A1 (en) * | 2008-02-15 | 2011-02-10 | Boehringer Ingelheim Vetmedica, Inc. | Methods and compositions for reducing the impact of enteric diseases |
AU2009303845B2 (en) * | 2008-10-16 | 2013-09-12 | Zoetis Llc | Torque teno virus (TTV) isolates and compositions |
US20100150959A1 (en) * | 2008-12-15 | 2010-06-17 | Vectogen Pty Ltd. | PCV 2-Based Methods and Compositions for the Treatment of Pigs |
AR078253A1 (es) | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad |
MX2012003972A (es) | 2009-10-02 | 2012-05-08 | Pionner Hi Bred International Inc | Regulacion a la baja de acc sintasa para mejorar el rendimiento de las plantas. |
US8846388B2 (en) | 2009-10-16 | 2014-09-30 | Zoetis Llc | Infectious clones of torque teno virus |
AU2010307250B2 (en) * | 2009-10-16 | 2013-09-26 | Zoetis Llc | Infectious clones of Torque teno virus |
JP2013507944A (ja) * | 2009-10-22 | 2013-03-07 | ウニヴェルシテート・ライプツィヒ | 汎血球減少症罹患仔ウシにおけるサーコウイルス(circovirus)の特定 |
EP2528931A4 (fr) * | 2010-01-25 | 2013-12-04 | Blood Systems Inc | Cyclovirus et procédé d'utilisation |
KR20110090711A (ko) * | 2010-02-04 | 2011-08-10 | 녹십자수의약품(주) | 신규한 돼지 써코바이러스 타입 2 및 그의 용도 |
TWI508974B (zh) | 2010-12-22 | 2015-11-21 | Sbc Virbac Ltd | 豬第二型環狀病毒(Porcine Circovirus Type 2)、含彼之免疫組合物、檢測套組及其應用 |
BR112013027860A2 (pt) | 2011-04-29 | 2016-11-29 | Pioneer Hi Bred Int | ácido nucleico isolado, planta ou célula vegetal, método para aumentar a capacidade do dreno, acelerar a remobilização e/ou a senescência e a secagem de grão em uma planta, método para aumentar a tolerância a seca na ausência de uma penalidade de produtividade sob condições sem seca, cassete de expressão e método para reduzir a expressão de zmme293 ou a atividade de zmme293 em uma planta |
HUP1100470A2 (en) | 2011-08-30 | 2013-03-28 | Mezoegazdasagi Biotechnologiai Kutatokoezpont | Nanoparticle-based veterinary vaccine |
EP2564869A1 (fr) * | 2011-09-02 | 2013-03-06 | Ceva Sante Animale | Protéines de capside synthétiques et leurs utilisations |
UA113192C2 (xx) | 2011-12-06 | 2016-12-26 | Імуногенна композиція проти цирковірусу свиней типу 2 (pcv2) | |
US9120859B2 (en) | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
UA114503C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
EP2961766B1 (fr) * | 2013-03-01 | 2019-04-10 | Boehringer Ingelheim Vetmedica, Inc. | Quantification de compositions de vaccin |
KR102217387B1 (ko) * | 2013-03-11 | 2021-02-19 | 주식회사 중앙백신연구소 | 재조합 효모 전세포(yeast whole cell)을 이용한 돼지 써코바이러스(PCV2) 서브유닛 백신과 그의 제조 방법 |
EP2789346A1 (fr) | 2013-04-11 | 2014-10-15 | CEVA Santé Animale SA | Vaccins et polypeptides de fusion |
EP2994162B1 (fr) | 2013-05-08 | 2021-04-07 | Pharmgate Biologics Inc. | Vaccin pour pcv2 et mycoplasme |
JP6821429B2 (ja) | 2013-09-25 | 2021-01-27 | ゾエティス・サービシーズ・エルエルシー | Pcv2b分岐ワクチン組成物及び使用方法 |
US9505808B2 (en) | 2013-10-02 | 2016-11-29 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 ORF2 protein variant and virus like particles composed thereof |
EP3034609A1 (fr) | 2014-12-19 | 2016-06-22 | Ceva Sante Animale | Virus de recombinaison de la variole porcine et vaccins |
EP3254692A1 (fr) | 2016-06-10 | 2017-12-13 | Ceva Sante Animale | Spv recombiné multivalent |
WO2019032830A1 (fr) | 2017-08-09 | 2019-02-14 | Dreamwell, Ltd. | Structure de support ajustable |
EP3720485A1 (fr) | 2017-12-08 | 2020-10-14 | Ceva Sante Animale | Virus recombiné de la variole porcine et vaccins associés |
US20220409715A1 (en) | 2018-03-26 | 2022-12-29 | Boehringer Ingelheim Animal Health USA Inc. | Method of producing an immunogenic composition |
KR20210019030A (ko) | 2018-06-11 | 2021-02-19 | 세바 상뜨 아니말르 | 돼지 써코바이러스에 대한 백신 접종 |
CA3194602A1 (fr) * | 2020-10-06 | 2022-04-14 | Abraham Oommen | Methode de detection d'arn ou d'adn a partir d'echantillons biologiques |
WO2023192936A2 (fr) * | 2022-03-30 | 2023-10-05 | Fred Hutchinson Cancer Center | Systèmes et procédés pour produire des cellules b qui expriment des anticorps sélectionnés et des produits géniques |
CN114736310B (zh) * | 2022-06-10 | 2022-10-28 | 北京华夏兴洋生物科技有限公司 | 产生圆环病毒2型病毒样颗粒的蛋白质及生物材料与应用 |
Family Cites Families (112)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US69750A (en) * | 1867-10-15 | Henry bean | ||
US69233A (en) * | 1867-09-24 | Joseph r | ||
FR2422956A1 (fr) | 1978-04-13 | 1979-11-09 | Pasteur Institut | Procede de detection et de caracterisation d'un acide nucleique ou d'une sequence de celui-ci, et reactif enzymatique pour la mise en oeuvre de ce procede |
FR2464269B1 (fr) | 1979-08-30 | 1986-04-18 | Anvar | Sequence nucleotidique codant l'antigene de surface du virus de l'hepatite b, procede permettant son obtention et antigene obtenu |
FR2518755B1 (fr) | 1981-12-23 | 1986-04-11 | Pasteur Institut | Sonde contenant un acide nucleique modifie et reconnaissable par des anticorps specifiques et utilisation de cette sonde pour detecter et caracteriser une sequence d'adn homologue |
US5833975A (en) | 1989-03-08 | 1998-11-10 | Virogenetics Corporation | Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence |
US4745051A (en) | 1983-05-27 | 1988-05-17 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
US5545412A (en) | 1985-01-07 | 1996-08-13 | Syntex (U.S.A.) Inc. | N-[1, (1-1)-dialkyloxy]-and N-[1, (1-1)-dialkenyloxy]-alk-1-yl-n,n,n-tetrasubstituted ammonium lipids and uses therefor |
US4946787A (en) | 1985-01-07 | 1990-08-07 | Syntex (U.S.A.) Inc. | N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
US5106733A (en) | 1987-06-25 | 1992-04-21 | Immunex Corporation | Bovine granulocyte-macrophage colony stimulating factor |
SU1538305A1 (ru) | 1987-07-21 | 1994-12-15 | Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Госагропрома СССР | Ассоциированная вакцина против лептоспироза и парвовирусной инфекции свиней |
US5069901A (en) | 1988-02-03 | 1991-12-03 | Jones Elaine V | Preparation of a recombinant subunit vaccine against pseudorabies infection |
EP0454735B1 (fr) | 1989-01-23 | 1996-05-22 | Auspharm International Limited | Composition de vaccin |
US5811103A (en) | 1989-03-19 | 1998-09-22 | Akzo Nobel N.V. | Hog cholera virus vaccine and diagnostic |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
CA2489769A1 (fr) | 1989-03-21 | 1990-10-04 | Philip L. Felgner | Expression des sequences polynocleotides exogenes chez un vertebre |
US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
DE69128361T3 (de) | 1990-05-29 | 2006-04-13 | Wyeth Holdings Corp. | Impfstoff gegen die pneumonie bei schweinen und verfahren zu seiner herstellung |
US5565205A (en) | 1990-08-16 | 1996-10-15 | Solvay Animal Health, Inc. | Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof |
WO1992005255A1 (fr) | 1990-09-13 | 1992-04-02 | Commonwealth Scientific And Industrial Research Organisation | Genes de cytokine d'origine ovine |
GB9023111D0 (en) | 1990-10-24 | 1990-12-05 | Wellcome Found | Expression system |
ES2150419T3 (es) | 1990-11-01 | 2000-12-01 | Univ Iowa State Res Found Inc | Procedimiento de atenuacion bacteriana y vacuna. |
EP0575491B1 (fr) | 1991-03-07 | 2003-08-13 | Virogenetics Corporation | Souche de vaccin mise au point par genie genetique |
ES2026827A6 (es) | 1991-03-26 | 1992-05-01 | Ercros Sa | Procedimiento para la produccion de una vacuna subunidad contra el parvovirus porcino. |
US5580557A (en) | 1991-10-09 | 1996-12-03 | Iowa State University Research Foundation, Inc. | Live, avirulent salmonella choleraesuis vaccine used for inducing an immune response in animals |
US6033904A (en) | 1992-01-13 | 2000-03-07 | Syntro Corporation | Recombinant swinepox virus |
US5382425A (en) | 1992-01-13 | 1995-01-17 | Syntro Corporation | Recombinant swinepox virus |
US5338543A (en) | 1992-02-27 | 1994-08-16 | Ambico, Inc. | Thimerosal inactivated mycoplasma hyopneumoniae vaccine |
US5679356A (en) | 1992-07-08 | 1997-10-21 | Schering Corporation | Use of GM-CSF as a vaccine adjuvant |
JP3149116B2 (ja) * | 1992-10-28 | 2001-03-26 | 信越化学工業株式会社 | ヒトパルボウイルスのエピトープ関連ペプチド |
EP0634936B1 (fr) * | 1992-11-09 | 2004-09-01 | Zonagen, Inc. | Methodes d'immunocontraception |
CZ289743B6 (cs) | 1993-02-08 | 2002-03-13 | Bayer Corporation | Izolát viru vepřového reprodukčního a respiračního syndromu PRRSV, způsob kultivace PRRSV, tkáňová kultura, způsob přípravy vakcíny a vakcína obsahující PRRSV izolát |
EP0620277A1 (fr) | 1993-03-18 | 1994-10-19 | Merck & Co. Inc. | Acides nucléiques comme produits pharmaceutiques |
EP0698245A1 (fr) | 1993-05-14 | 1996-02-28 | Mds Health Group Limited | Fichier electronique pour tests de microbiologie et etablissement de leurs rapports |
EP1624068A1 (fr) | 1993-06-01 | 2006-02-08 | Life Technologies Inc. | Vaccination génétique avec des lipides cationiques |
JP3626187B2 (ja) | 1993-06-07 | 2005-03-02 | バイカル インコーポレイテッド | 遺伝子治療に適するプラスミド |
US6015686A (en) | 1993-09-15 | 2000-01-18 | Chiron Viagene, Inc. | Eukaryotic layered vector initiation systems |
FR2711670B1 (fr) | 1993-10-22 | 1996-01-12 | Pasteur Institut | Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite. |
GB2285766B (en) | 1994-01-21 | 1997-07-23 | Ecc Int Ltd | Ceramic casting composition |
KR0121105B1 (ko) * | 1994-02-04 | 1997-11-10 | 문정환 | 선입선출메모리 버스장치 |
WO1995024929A2 (fr) | 1994-03-15 | 1995-09-21 | Brown University Research Foundation | Systeme de liberation de genes polymeres |
AU694519B2 (en) | 1994-04-29 | 1998-07-23 | Immuno Aktiengesellschaft | Recombinant poxviruses with foreign polynucleotides in essential regions |
WO1995030437A1 (fr) | 1994-05-10 | 1995-11-16 | American Home Products Corporation | Vaccin vivant modifie, ameliore, contre le virus respiratoire syncytial bovin (vrsb) |
DK53595A (da) | 1994-05-13 | 1995-11-14 | Iberica Cyanamid | Rekombinante PRRSV-proteiner, diagnostiske kits og vaccine indeholdende sådanne rekombinante PRRSV-proteiner |
US5719131A (en) | 1994-12-09 | 1998-02-17 | Genzyme Corporation | Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules |
US5840306A (en) * | 1995-03-22 | 1998-11-24 | Merck & Co., Inc. | DNA encoding human papillomavirus type 18 |
US6043232A (en) | 1997-07-23 | 2000-03-28 | Nitromed, Inc. | Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs |
JPH11504631A (ja) | 1995-04-25 | 1999-04-27 | バイカル インコーポレイテッド | Dna/脂質複合体の単一バイアル製剤 |
US5681658A (en) * | 1995-05-30 | 1997-10-28 | Aluminum Company Of America | Gelation-resistant alumina |
US5885823A (en) | 1995-06-05 | 1999-03-23 | Nobl Laboratories, Inc. | Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
CN1194001A (zh) | 1995-06-07 | 1998-09-23 | 埃斯库拉普公司 | 鸡贫血症病毒的中和构象表位 |
US5820869A (en) | 1995-06-07 | 1998-10-13 | American Home Products Corporation | Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection |
US6019980A (en) | 1995-06-07 | 2000-02-01 | Connaught Laboratories Limited | Nucleic acid respiratory syncytial virus vaccines |
US5705385A (en) | 1995-06-07 | 1998-01-06 | Inex Pharmaceuticals Corporation | Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
US5795872A (en) | 1995-09-19 | 1998-08-18 | Pharmadigm, Inc. | DNA construct for immunization |
FR2751224B1 (fr) | 1996-07-19 | 1998-11-20 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs |
DE69704011T2 (de) | 1996-10-09 | 2001-06-07 | Akzo Nobel Nv | Europäische Vakzinstämme des Fortplanzungs-Atmungs-Syndromsvirus des Sweins (PRRSV) |
WO1998040499A1 (fr) | 1997-03-10 | 1998-09-17 | Heather Lynn Davis | Apport de genes dans l'epithelium muqueux a des fins therapeutiques ou d'immunisation |
US6004777A (en) | 1997-03-12 | 1999-12-21 | Virogenetics Corporation | Vectors having enhanced expression, and methods of making and uses thereof |
US5990091A (en) | 1997-03-12 | 1999-11-23 | Virogenetics Corporation | Vectors having enhanced expression, and methods of making and uses thereof |
US20030215445A1 (en) * | 1997-05-23 | 2003-11-20 | Ginette Serrero | Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
US6143334A (en) * | 1997-10-03 | 2000-11-07 | Sargento Foods Inc. | Pasta filata method for manufacturing Swiss-type cheeses |
US7211379B2 (en) | 1997-10-03 | 2007-05-01 | Merial Sas | Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2 |
US7192594B2 (en) * | 1997-10-03 | 2007-03-20 | Merial Limited | Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
US6391314B1 (en) * | 1997-10-03 | 2002-05-21 | Merial | Porcine circoviruses vaccines diagnostic reagents |
FR2769322B1 (fr) | 1997-10-03 | 2002-03-08 | Merial Sas | Nouveaux circovirus porcins, vaccins et reactifs de diagnostic |
FR2769321B1 (fr) | 1997-10-03 | 2001-10-26 | Merial Sas | Nouveaux circovirus porcins, vaccins et reactifs de diagnostics |
US6517843B1 (en) * | 1999-08-31 | 2003-02-11 | Merial | Reduction of porcine circovirus-2 viral load with inactivated PCV-2 |
FR2781159B1 (fr) | 1998-07-06 | 2000-10-06 | Merial Sas | Vaccin circovirus et parvovirus porcin |
UA78180C2 (uk) * | 1997-10-03 | 2007-03-15 | Меріаль | Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти |
US6165493A (en) | 1997-10-22 | 2000-12-26 | New York Blood Center, Inc. | "Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections" |
FR2772047B1 (fr) | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
US20040062775A1 (en) | 1997-12-05 | 2004-04-01 | Agence Francaise De Securite Sanitaire Des Aliments | Circovirus sequences associated with piglet weight loss disease (PWD) |
PT1037909E (pt) * | 1997-12-11 | 2007-09-07 | Merial Sas | Síndrome multi-sistémica do definhamento pós-desmame de porcos |
US6287856B1 (en) * | 1998-03-13 | 2001-09-11 | University Of Georgia Research Foundation, Inc. | Vaccines against circovirus infections |
US6294176B1 (en) | 1998-07-10 | 2001-09-25 | Schering-Plough Veterinary Corp. | Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species |
AU1131200A (en) | 1998-10-23 | 2000-05-15 | Heska Corporation | Cationic lipid-mediated enhancement of nucleic acid immunization of cats |
US6143333A (en) | 1998-11-13 | 2000-11-07 | Purina Mills, Inc. | Method of preparing a packaged fish attractant block |
FR2789695B1 (fr) | 1999-02-11 | 2003-03-07 | Merial Sas | Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs |
US6943152B1 (en) | 1999-06-10 | 2005-09-13 | Merial | DNA vaccine-PCV |
US6497883B1 (en) | 1999-06-10 | 2002-12-24 | Merial | Porcine circovirus recombinant poxvirus vaccine |
US6139179A (en) | 1999-09-03 | 2000-10-31 | Davis-Standard Corporation | Extruder screw having multi-channeled barrier section |
US6179461B1 (en) | 1999-09-03 | 2001-01-30 | Davis-Standard Corporation | Extruder screw |
GB9921147D0 (en) | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
GB9921146D0 (en) | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
WO2001017556A1 (fr) | 1999-09-07 | 2001-03-15 | Shionogi & Co., Ltd. | Préparations vaccinales administrables par les muqueuses |
WO2001034609A1 (fr) * | 1999-11-10 | 2001-05-17 | Optische Werke G. Rodenstock | Derives indenochromes heterocycliquement anneles |
US6366601B1 (en) * | 1999-11-17 | 2002-04-02 | Motorola, Inc. | Variable rate spread spectrum communication method and apparatus |
US7233407B1 (en) * | 2000-02-02 | 2007-06-19 | Xerox Corporation | Document production system for capturing web page content |
JP3363419B2 (ja) * | 1999-12-24 | 2003-01-08 | 住友ゴム工業株式会社 | 重荷重用ラジアルタイヤ |
MXPA02012352A (es) | 2000-06-15 | 2004-09-06 | Purdue Research Foundation | Vacuna para temblores congenitos en cerdos. |
JP4768106B2 (ja) | 2000-07-31 | 2011-09-07 | スリーエム イノベイティブ プロパティズ カンパニー | 接着剤組成物及び熱剥離容易な接着構造 |
DE10044648A1 (de) * | 2000-09-08 | 2002-03-21 | Aventis Behring Gmbh | Verfahren zur Vermehrung oder zur Entfernung von Cirocoviren aus biologischem Material |
DE10044646A1 (de) | 2000-09-08 | 2002-04-04 | Horsch Maschinen Gmbh | Spritzgestängeführung |
DE10051562A1 (de) * | 2000-10-18 | 2002-04-25 | Emitec Emissionstechnologie | Beheizbarer Wabenkörper mit zwei verschiedenen Beschichtungen |
US6572081B2 (en) * | 2000-12-27 | 2003-06-03 | Nkf Kabel B.V. | Installation of guide tubes in a protective duct |
JP4038127B2 (ja) * | 2001-03-27 | 2008-01-23 | ユニバーシティ オブ サスカチュワン | サーコウイルスの培養方法 |
AUPR567401A0 (en) | 2001-06-14 | 2001-07-12 | University Of Melbourne, The | Circovirus vaccines |
US7279166B2 (en) | 2001-12-12 | 2007-10-09 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
US7276353B2 (en) | 2001-12-12 | 2007-10-02 | Virginia Tech Intellectual Properties, Inc. | Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof |
US20030215455A1 (en) | 2002-05-14 | 2003-11-20 | Bailey Reynolds | Vaccine stabilizer and method of use |
CA2507520C (fr) * | 2002-11-28 | 2007-01-23 | Research In Motion Limited | Antennes a bandes multiples avec structures de connexion et a fentes rayonnantes |
US7288529B2 (en) * | 2003-04-24 | 2007-10-30 | New York University | ALK protein tyrosine kinase, cells and methods embodying and using same |
CA2533559C (fr) | 2003-07-25 | 2013-07-02 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia intracellularis d'origine europeenne, vaccins, agents diagnostiques et procedes d'utilisation de ceux-ci |
US20050279889A1 (en) | 2004-06-08 | 2005-12-22 | Safe Flight Instrument Corporation | Variable wing spacecraft |
US7833707B2 (en) * | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
WO2006074986A2 (fr) | 2005-01-13 | 2006-07-20 | Boehringer Ingelheim Vetmedica Gmbh | Vaccins ameliores contre le srrp |
MX2007012786A (es) | 2005-04-13 | 2008-01-11 | Merial Ltd | Ensayo para produccion de circovirus porcino. |
DK2371382T3 (en) | 2005-12-29 | 2016-06-13 | Boehringer Ingelheim Vetmedica Inc | Use of a PCV2 immunogenic composition to reduce the clinical signs in swine |
US8377070B2 (en) * | 2007-05-17 | 2013-02-19 | Michael T. Gauthier | Compressor distractor tool |
US8214576B2 (en) | 2009-03-03 | 2012-07-03 | Vmware, Inc. | Zero copy transport for target based storage virtual appliances |
-
1997
- 1997-12-05 FR FR9715396A patent/FR2772047B1/fr not_active Expired - Lifetime
-
1998
- 1998-12-04 PT PT98958957T patent/PT1036180E/pt unknown
- 1998-12-04 EP EP08154913.1A patent/EP1992696B1/fr not_active Expired - Lifetime
- 1998-12-04 PT PT81549131T patent/PT1992696E/pt unknown
- 1998-12-04 EP EP98958957A patent/EP1036180B2/fr not_active Expired - Lifetime
- 1998-12-04 DK DK08154912.3T patent/DK2000535T3/da active
- 1998-12-04 DK DK10184556.8T patent/DK2316925T3/da active
- 1998-12-04 ES ES10184626.9T patent/ES2548146T3/es not_active Expired - Lifetime
- 1998-12-04 ES ES98958957T patent/ES2317679T5/es not_active Expired - Lifetime
- 1998-12-04 PT PT81549123T patent/PT2000535E/pt unknown
- 1998-12-04 EP EP10184556.8A patent/EP2316925B1/fr not_active Expired - Lifetime
- 1998-12-04 EP EP10184626.9A patent/EP2330188B1/fr not_active Expired - Lifetime
- 1998-12-04 AT AT98958957T patent/ATE412664T1/de active
- 1998-12-04 PT PT101845568T patent/PT2316925E/pt unknown
- 1998-12-04 WO PCT/FR1998/002634 patent/WO1999029871A2/fr active Search and Examination
- 1998-12-04 AU AU14916/99A patent/AU1491699A/en not_active Abandoned
- 1998-12-04 DK DK98958957.7T patent/DK1036180T4/da active
- 1998-12-04 ES ES08154913.1T patent/ES2458309T3/es not_active Expired - Lifetime
- 1998-12-04 EP EP15172572.8A patent/EP3002331A1/fr not_active Withdrawn
- 1998-12-04 ES ES10184556.8T patent/ES2548145T3/es not_active Expired - Lifetime
- 1998-12-04 DK DK10184626.9T patent/DK2330188T3/da active
- 1998-12-04 DK DK08154913.1T patent/DK1992696T3/da active
- 1998-12-04 PT PT101846269T patent/PT2330188E/pt unknown
- 1998-12-04 DE DE69840174T patent/DE69840174D1/de not_active Expired - Lifetime
- 1998-12-04 EP EP08154912.3A patent/EP2000535B1/fr not_active Expired - Lifetime
- 1998-12-04 ES ES08154912.3T patent/ES2456959T3/es not_active Expired - Lifetime
-
2000
- 2000-02-28 US US09/514,245 patent/US6703023B1/en not_active Expired - Lifetime
-
2003
- 2003-04-09 US US10/409,613 patent/US20040076635A1/en not_active Abandoned
- 2003-05-21 US US10/442,180 patent/US20040091502A1/en not_active Abandoned
- 2003-08-08 US US10/637,011 patent/US7223594B2/en not_active Expired - Lifetime
- 2003-11-21 US US10/718,266 patent/US7148015B2/en not_active Expired - Lifetime
- 2003-11-21 US US10/718,264 patent/US7179472B2/en not_active Expired - Lifetime
-
2004
- 2004-02-11 US US10/775,337 patent/US20050008651A1/en not_active Abandoned
-
2005
- 2005-07-08 US US11/176,667 patent/US7244433B2/en not_active Expired - Lifetime
- 2005-10-31 US US11/262,514 patent/US7261898B2/en not_active Expired - Lifetime
-
2006
- 2006-07-17 US US11/487,589 patent/US7407803B2/en not_active Expired - Fee Related
- 2006-07-19 US US11/488,926 patent/US7405075B2/en not_active Expired - Fee Related
- 2006-07-19 US US11/488,885 patent/US7297537B2/en not_active Expired - Fee Related
- 2006-10-27 US US11/588,305 patent/US7323330B2/en not_active Expired - Fee Related
- 2006-10-27 US US11/588,306 patent/US7425444B2/en not_active Expired - Fee Related
- 2006-10-27 US US11/588,237 patent/US7722883B2/en not_active Expired - Fee Related
- 2006-10-27 US US11/588,291 patent/US7740865B2/en not_active Expired - Fee Related
- 2006-10-27 US US11/588,302 patent/US7390494B2/en not_active Expired - Fee Related
-
2007
- 2007-11-01 US US11/979,296 patent/US7740866B2/en not_active Expired - Fee Related
- 2007-12-20 US US12/003,188 patent/US7741026B2/en not_active Expired - Fee Related
- 2007-12-28 US US12/003,558 patent/US7604808B2/en not_active Expired - Fee Related
-
2008
- 2008-07-03 US US12/216,410 patent/US7758865B2/en not_active Expired - Fee Related
- 2008-07-28 US US12/219,774 patent/US8715690B2/en not_active Expired - Fee Related
-
2009
- 2009-05-19 HK HK09104574.7A patent/HK1125676A1/xx not_active IP Right Cessation
- 2009-05-19 HK HK11111955.7A patent/HK1158254A1/xx not_active IP Right Cessation
- 2009-05-19 HK HK11113272.9A patent/HK1158694A1/xx not_active IP Right Cessation
- 2009-06-09 HK HK09105144.5A patent/HK1126522A1/xx not_active IP Right Cessation
- 2009-09-17 US US12/561,946 patent/US20100226934A1/en not_active Abandoned
- 2009-09-17 US US12/561,829 patent/US20100166791A1/en not_active Abandoned
- 2009-09-17 US US12/561,881 patent/US20100172924A1/en not_active Abandoned
- 2009-10-19 US US12/588,526 patent/US20110135677A1/en not_active Abandoned
- 2009-10-19 US US12/588,525 patent/US20110033489A1/en not_active Abandoned
- 2009-11-13 US US12/618,485 patent/US7951907B2/en not_active Expired - Fee Related
- 2009-12-11 US US12/636,180 patent/US20100215690A1/en not_active Abandoned
-
2010
- 2010-01-08 US US12/684,506 patent/US20100203072A1/en not_active Abandoned
- 2010-01-11 US US12/685,243 patent/US20100221276A1/en not_active Abandoned
- 2010-03-05 US US12/718,197 patent/US8124723B2/en not_active Expired - Fee Related
- 2010-03-05 US US12/718,183 patent/US20100189735A1/en not_active Abandoned
- 2010-03-05 US US12/718,158 patent/US20100189733A1/en not_active Abandoned
- 2010-03-05 US US12/718,168 patent/US20100189734A1/en not_active Abandoned
- 2010-03-05 US US12/718,153 patent/US20100189732A1/en not_active Abandoned
- 2010-03-05 US US12/718,214 patent/US20100189743A1/en not_active Abandoned
- 2010-04-28 US US12/768,897 patent/US20100209453A1/en not_active Abandoned
-
2011
- 2011-09-06 US US13/226,013 patent/US8415525B2/en not_active Expired - Fee Related
- 2011-10-20 US US13/277,582 patent/US8916353B2/en not_active Expired - Fee Related
-
2014
- 2014-04-11 CY CY20141100270T patent/CY1115405T1/el unknown
- 2014-05-05 CY CY20141100318T patent/CY1115424T1/el unknown
- 2014-08-14 BE BE2014C049C patent/BE2014C049I2/fr unknown
- 2014-08-14 BE BE2014C050C patent/BE2014C050I2/fr unknown
- 2014-08-14 NL NL300686C patent/NL300686I2/nl unknown
- 2014-08-14 NL NL300685C patent/NL300685I2/nl unknown
- 2014-08-18 LU LU92524C patent/LU92524I2/fr unknown
- 2014-08-18 LU LU92523C patent/LU92523I2/fr unknown
- 2014-08-19 FR FR14C0061C patent/FR14C0061I2/fr active Active
- 2014-08-19 FR FR14C0062C patent/FR14C0062I2/fr active Active
- 2014-08-19 CY CY2014036C patent/CY2014036I2/el unknown
- 2014-08-19 CY CY2014035C patent/CY2014035I2/el unknown
- 2014-11-14 US US14/541,516 patent/US9700613B2/en not_active Expired - Fee Related
- 2014-11-14 US US14/541,268 patent/US9717784B2/en not_active Expired - Fee Related
-
2015
- 2015-09-30 CY CY20151100872T patent/CY1116761T1/el unknown
- 2015-10-09 CY CY20151100916T patent/CY1116837T1/el unknown
-
2016
- 2016-09-07 HK HK16110634.3A patent/HK1222415A1/zh unknown
-
2017
- 2017-07-28 US US15/662,772 patent/US10052375B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE2014C050I2 (en) | Circovirus sequences associated with piglet weight loss disease (PWD) | |
DE69526973T3 (de) | Sequenzen von hepatitis-c-virus genotype 7, und deren verwendung als vorbeugende, therapeutische und diagnostische mittel | |
Ridpath et al. | Segregation of bovine viral diarrhea virus into genotypes | |
DE69033425T3 (de) | HCV-Isolat J-1 | |
WO1998050554A3 (fr) | POLYNUCLEOTIDES ET POLYPEPTIDES D'$i(ENTEROCOCCUS FAECALIS) | |
EP1167542A3 (fr) | Sonde pour diagnostiquer des maladies infectieuses liées à Enterococcus Faecalis | |
CA2005291A1 (fr) | Instruments de diagnostic du virus de la peritonite infectieuse des felins | |
CA2108466A1 (fr) | Sequences genomiques du vhc pour le diagnostic et la therapie | |
ATE366314T1 (de) | Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays | |
EP1197568A3 (fr) | Détection et typage du virus de l'hépatite C à l'aide de séquences d'acides nucléiques 5'UTR et NS5 | |
RU93058449A (ru) | Hcv геномные последовательности для диагностических и терапевтических целей | |
ATE338821T1 (de) | Strukturprotein von aav, seine herstellung und verwendung | |
ATE420190T1 (de) | Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen | |
CA2045323A1 (fr) | Adn-c du genome du virus de l'hepatite non-a, non-b et polypeptide antigenique | |
CA2215328A1 (fr) | Nouvelles sequences d'adn du cytomegalovirus humain | |
Odemuyiwa et al. | An outbreak of African swine fever in Nigeria: virus isolation and molecular characterization of the VP72 gene of a first isolate from West Africa | |
Banks | DNA restriction fragment length polymorphism among British isolates of Aujeszky's disease virus: use of the polymerase chain reaction to discriminate among strains | |
EP0297378A3 (fr) | 2,5-Dihydropyrroles | |
WO1999058639A3 (fr) | Proteines de structure du virus de la maladie affectant le pancreas des poissons et utilisations de ces dernieres | |
CA2226457A1 (fr) | Oligonucleotides specifiques contre le papillomavirus humain | |
AU4136797A (en) | Novel semaphorin gene: semaphorin y | |
WO1999004029A3 (fr) | Virus de l'hepatite e du porc et ses utilisations | |
CA2066998A1 (fr) | Virus de la varicella-zona recombinant et procede de construction | |
WO2000028039A3 (fr) | Identification de genotypes senv | |
ATE124991T1 (de) | Humaner papillomvirus typ 57, seine dna und die davon kodierten proteine. |